Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer

IMPORTANCE: Adjuvant chemotherapy in patients with stage III colon cancer prevents recurrence by eradicating minimal residual disease. However, which patients remain at high risk of recurrence after completing standard adjuvant treatment cannot currently be determined. Postsurgical circulating tumor...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Oncol
Autors principals: Tie, Jeanne, Cohen, Joshua D., Wang, Yuxuan, Christie, Michael, Simons, Koen, Lee, Margaret, Wong, Rachel, Kosmider, Suzanne, Ananda, Sumitra, McKendrick, Joseph, Lee, Belinda, Cho, Jin Hee, Faragher, Ian, Jones, Ian T., Ptak, Janine, Schaeffer, Mary J., Silliman, Natalie, Dobbyn, Lisa, Li, Lu, Tomasetti, Cristian, Papadopoulos, Nicholas, Kinzler, Kenneth W., Vogelstein, Bert, Gibbs, Peter
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2019
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6802034/
https://ncbi.nlm.nih.gov/pubmed/31621801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2019.3616
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars